1. Home
  2. TENX vs NYC Comparison

TENX vs NYC Comparison

Compare TENX & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • NYC
  • Stock Information
  • Founded
  • TENX 1967
  • NYC 2013
  • Country
  • TENX United States
  • NYC United States
  • Employees
  • TENX N/A
  • NYC N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • NYC Real Estate
  • Sector
  • TENX Health Care
  • NYC Finance
  • Exchange
  • TENX Nasdaq
  • NYC Nasdaq
  • Market Cap
  • TENX 21.6M
  • NYC 24.9M
  • IPO Year
  • TENX N/A
  • NYC N/A
  • Fundamental
  • Price
  • TENX $6.17
  • NYC $12.62
  • Analyst Decision
  • TENX Strong Buy
  • NYC
  • Analyst Count
  • TENX 3
  • NYC 0
  • Target Price
  • TENX $16.00
  • NYC N/A
  • AVG Volume (30 Days)
  • TENX 35.4K
  • NYC 6.2K
  • Earning Date
  • TENX 08-12-2025
  • NYC 08-08-2025
  • Dividend Yield
  • TENX N/A
  • NYC N/A
  • EPS Growth
  • TENX N/A
  • NYC N/A
  • EPS
  • TENX N/A
  • NYC N/A
  • Revenue
  • TENX N/A
  • NYC $58,397,000.00
  • Revenue This Year
  • TENX N/A
  • NYC $8.40
  • Revenue Next Year
  • TENX N/A
  • NYC $1.62
  • P/E Ratio
  • TENX N/A
  • NYC N/A
  • Revenue Growth
  • TENX N/A
  • NYC N/A
  • 52 Week Low
  • TENX $2.80
  • NYC $7.55
  • 52 Week High
  • TENX $7.89
  • NYC $13.60
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.83
  • NYC 62.16
  • Support Level
  • TENX $5.62
  • NYC $8.85
  • Resistance Level
  • TENX $6.35
  • NYC $10.50
  • Average True Range (ATR)
  • TENX 0.46
  • NYC 0.85
  • MACD
  • TENX 0.01
  • NYC 0.35
  • Stochastic Oscillator
  • TENX 41.49
  • NYC 79.66

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Share on Social Networks: